INFORMATION FOR
News
For the past 25 years, Women's Health Research at Yale has been investigating conditions of high morbidity and mortality in women and understanding sex and gender differences that affect health outcomes.
After discovering a specific lupus antibody that can penetrate cancer cells and, with a grant from Women's Health Research at Yale, showing it makes cancer cells vulnerable to standard treatments, Dr. Peter Glazer and his colleagues are moving a treatment to clinical trials.
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
Women’s Health Research at Yale (WHRY) is funding a study to explain how well-known genetic mutations can lead to ovarian cancer.
When it comes to life-threatening diseases, people understandably want to maximize their chances for survival. So when considering the best practices to check for breast cancer, it makes intuitive sense that doctors and patients would prefer to screen early and often.
While guidelines offer slight disagreements about whether women should begin annual screening mammograms at a certain age, experts stress that recommendations have more in common than not.
Ann Baker Pepe embraced her mother’s attitude about helping others when she and her husband, Greg Pepe, donated to WHRY.
Women’s Health Research at Yale has been awarded a three-year grant from The Community Foundation for Greater New Haven to support heart and cancer research.
Spreading awareness about male breast cancer has become a calling for Catherine Szerszen and her fiancé Bob Havens ever since Bob was diagnosed with stage I breast cancer in 2023.
In an interview, Rachel Perry, PhD, discusses the link between insulin and cancer, a surprising finding in her research, and the future of precision medicine for metabolism-related cancers.
Smilow Shares with Primary Care: Breast Cancer
Monica G. Valero, MD, assistant professor of surgery (oncology) and director of the Hispanic Breast Cancer Program, has received a prestigious one-year pilot grant from the American Cancer Society (ACS) to advance breast cancer care among the Hispanic population. The prestigious award affirms the Department of Surgery’s commitment to tackling health inequities on a national scale and locally.
Smilow Cancer Hospital, in partnership with the Norma Pfriem Breast Center, has opened a new patient care location in Bridgeport, CT to provide residents in the greater Bridgeport area with convenient access to Smilow Cancer Hospital specialty breast surgical care and expertise.
The Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center provides coordinated, state-of-the-art care for patients with benign and malignant diseases of the breast.
The Prudence Stiltor Crozier Breast Surgical Oncology Annual Lectureship and Resource Fund, to be guided by Mehra Goldhan, MD, MBA, aims to educate the next generation of breast surgeons.
Ellie Proussaloglou, MD, assistant professor of surgery (breast surgical oncology) discusses her fellowship at Yale and the transition from fellowship to being an attending.
New research illustrates remarkably lower use of immediate breast reconstruction in older women of Asian descent.
In a new study led by Yale Cancer Center researchers at Yale School of Medicine, their findings revealed important differences in the genetic makeup of HER2-low advanced breast cancers — a discovery that could lead to better treatment options for patients.
A team of researchers led by senior author Dr. David Rimm and first author Charles “Jack” Robbins at Yale Cancer Center evaluated a new “selective” biomarker called Troplex™, which assesses HER2, TROP2, and cytokeratin using quantitative immunofluorescence.
Yale Cancer Center researchers at Yale School of Medicine will present new research at the 46th annual San Antonio Breast Cancer Symposium (SABCS) from December 5 to 9.